Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

419
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
419
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

182
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
182
Neural Regulation01:37

Neural Regulation

39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

223
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
223

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Investigating smiling asymmetries in Parkinson's disease through the whistle-smile reflex.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Neurodegenerative diseases and environmental risk factors: an overview of the available scientific evidence.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Stereotypies misdiagnosed as functional neurological disorder in late-onset Niemann-Pick C.

Parkinsonism & related disorders·2026
Same author

Genetic and environmental risk factors of Parkinsonism.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Functional Neurological Disorder during Foscarbidopa/Foslevodopa Infusion in PRKN-Associated Parkinsonism.

Movement disorders clinical practice·2026
Same author

Outcomes predictors in patients with basilar artery occlusion and mild deficits, treated with mechanical thrombectomy: A multicenter retrospective observational study.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same journal

Advances in CSF1R-related disorder: novel mutations, dopaminergic imaging, and overcoming underdiagnosis.

Neurologia i neurochirurgia polska·2026
Same journal

Electrophysiological markers of subclinical central nervous system involvement in patients with non-small-cell lung cancer without brain metastases.

Neurologia i neurochirurgia polska·2026
Same journal

Highlighting the CSF1R mutational spectrum: c.2549C>T variant in late-onset leukoencephalopathy mimicking multiple sclerosis.

Neurologia i neurochirurgia polska·2026
Same journal

Sacroiliac joint manipulation for low back and radicular pain: outcomes in a 100-patient single-center cohort.

Neurologia i neurochirurgia polska·2026
Same journal

Beyond leukodystrophy: parkinsonism and microglial failure in CSF1R p.Ile794Thr.

Neurologia i neurochirurgia polska·2026
Same journal

Genetic screening for CSF1R variants in patients with dementia, parkinsonism, and multiple sclerosis.

Neurologia i neurochirurgia polska·2026
查看所有相关文章

相关实验视频

Updated: May 24, 2025

The 6-hydroxydopamine Rat Model of Parkinson's Disease
08:10

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

10.4K

帕金森病的临床亚型真的存在吗?

Marta Filidei1, Luca Marsili2, Carlo Colosimo3

  • 1Department of Neurology, Santa Maria University Hospital, Terni, Italy.

Neurologia i neurochirurgia polska
|March 3, 2025
PubMed
概括
此摘要是机器生成的。

帕金森病 (PD) 亚型缺乏生物支持,阻碍了预后和治疗预测. 未来的研究应该专注于生物分类,辅助生物标志物,以更好地了解PD病因学.

关键词:
帕金森氏症 帕金森氏症这是一种α-synuclein.生物标志物 生物标志物诊断标准 诊断标准 诊断标准 诊断标准

更多相关视频

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.5K
Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.2K

相关实验视频

Last Updated: May 24, 2025

The 6-hydroxydopamine Rat Model of Parkinson's Disease
08:10

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

10.4K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.5K
Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.2K

科学领域:

  • 神经学 神经学
  • 神经科学是一个神经科学.
  • 医学研究 医学研究

背景情况:

  • 帕金森病 (PD) 在临床表现,进展和治疗反应方面表现出显著的异质性.
  • 这种变异性表明存在不同的临床亚型.
  • 之前的分类工作已经根据临床特征和有限的生物标志物确定了"良性"和"恶性"亚型.

研究的目的:

  • 审查有关帕金森病亚型的现有文献.
  • 检查拟议的生物标志物用于生物分类.
  • 概述遗传学和病理学在PD分类中的作用.

主要方法:

  • 关于帕金森病亚型研究的文献综述.
  • 对拟议的生物标志物的分析 (流体,神经成像,神经生理学).
  • 在PD分类中检查遗传和病理因素.

主要成果:

  • 目前的PD临床亚型缺乏可靠的生物验证.
  • 现有的亚型并不能可靠地预测预后或治疗反应.
  • 生物标志物对于朝着PD的生物分类迈进至关重要.

结论:

  • 帕金森病的临床亚型尚未阐明其病因.
  • 需要转向生物分类,利用生物标志物的进步.
  • 未来的研究应该集中在生物标志物上,以克服临床诊断的局限性.